Medical MCQ
MCQ Ebook
Biochemistry
Microbiology
Pathology
MCQ Subjects
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
MCQ Exam
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
All MCQs
Term Of Use
Privacy Policy
Contact Us
About Us
Home
Ebooks
Questions
Search
Psychiatry
Which of the following statements comparing serotonin-dopamine antagonists (SDAs) with dopamine receptor antagonists (DRAs) is true?
DRAs is first choice of treatment for schizophrenia.
SDAs produce more neurological adverse effects.
SDAs produce more extrapyramidal symptoms.
SDAs affect both serotonin and glutamate receptors.
Questions
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100